CIK 0001756262
- Large accelerated filer
TransMedics Group, Inc.
Sign in to watch- Ticker
- TMDX
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- Operating
- Phone
- +1 978-552-0900
- Business address
- 200 MINUTEMAN ROAD, ANDOVER, MA, 01810
- 4 Planned sale Chief Financial Officer sold 15,000 shares at $74.01 ($1,110,150)
- 4 Planned sale Chief Commercial Officer sold 1,417 shares at an average $87.80 ($124,413)
- 4 Open-market sale Chief Financial Officer sold 1,903 shares at $87.63 ($166,760)
- 4 Planned sale Chief Commercial Officer sold 10,000 shares at an average $82.99 ($829,892)
- 4 Planned sale Chief Financial Officer sold 15,000 shares at $82.80 ($1,242,000)
- 4 Planned sale Director sold 13,380 shares at an average $83.63 ($1,118,955)
- 4 Grant or award Chief Commercial Officer acquired 12,127 shares (grant or award)
- 4 Grant or award Corcoran Nicholas acquired 11,441 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 12,127 shares (grant or award)
- 4 Grant or award President & CEO acquired 36,755 shares (grant or award)
- 4 Planned sale Chief Commercial Officer sold 3,108 shares at $90.00 ($279,720)
- 4 Planned sale Chief Commercial Officer sold 3,826 shares at an average $90.02 ($344,432)
- 4 Planned sale Chief Commercial Officer sold 736 shares at $90.09 ($66,306)
- 4 Planned sale Director sold 7,157 shares at an average $86.38 ($618,209)
- 4 Planned sale Chief Financial Officer sold 15,000 shares at $85.45 ($1,281,750)
- 4 Planned sale Chief Commercial Officer sold 2,330 shares at $90.09 ($209,910)
- 4 Planned sale Chief Commercial Officer sold 10,000 shares at an average $80.41 ($804,088)
- 4 Planned sale Chief Financial Officer sold 15,000 shares at $77.07 ($1,156,050)
- 4 Open-market sale VP, Global Regulatory Affairs sold 4,122 shares at $75.10 ($309,562)
- 4 Open-market sale President & CEO sold 7,500 shares at an average $74.40 ($558,033)
Page 6 of 18 · 358 filings